November 16, 2018 — The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E….Original Article
FDA Approves Aemcolo (rifamycin) to Treat Travelers’ Diarrhea
